Mithradote Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1M

  • Investors
  • 2

Mithradote Bio General Information

Description

Developer of a novel medication intended to develop safe and effective products that protect intended targets of drug-facilitated sexual assault. The company is developing a sublingual strip that allows for rapid absorption and drug neutralization and can be taken if the need arises, enabling patients to help prevent drug-facilitated sexual assault.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1117 South Calfornia Avenue
  • Palo Alto, CA 94304
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1117 South Calfornia Avenue
  • Palo Alto, CA 94304
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mithradote Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 02-Oct-2024 $1M Completed Pre-Clinical Trials
To view Mithradote Bio’s complete valuation and funding history, request access »

Mithradote Bio Patents

Mithradote Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4798211-A1 Rapidly degrading formulations for reversing an attempted incapacitation Pending 23-Oct-2023
WO-2025090681-A1 Rapidly degrading formulations for reversing an attempted incapacitation Inactive 23-Oct-2023

Mithradote Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mithradote Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Taho Pharmaceuticals Corporation Minority
Vickers Venture Partners Corporate Venture Capital Minority
To view Mithradote Bio’s complete investors history, request access »

Mithradote Bio FAQs

  • When was Mithradote Bio founded?

    Mithradote Bio was founded in 2023.

  • Where is Mithradote Bio headquartered?

    Mithradote Bio is headquartered in Palo Alto, CA.

  • What is the size of Mithradote Bio?

    Mithradote Bio has 2 total employees.

  • What industry is Mithradote Bio in?

    Mithradote Bio’s primary industry is Drug Discovery.

  • Is Mithradote Bio a private or public company?

    Mithradote Bio is a Private company.

  • What is Mithradote Bio’s current revenue?

    The current revenue for Mithradote Bio is .

  • How much funding has Mithradote Bio raised over time?

    Mithradote Bio has raised $1M.

  • Who are Mithradote Bio’s investors?

    Taho Pharmaceuticals and Vickers Venture Partners have invested in Mithradote Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process